E2F7 and colonic neoplasm: In conclusion, our study reported that E2F7 downregulated the expression of miR-199b, leading to the upregulation of the miR-199b target USP47 that stabilized MAPK, promoting colon cancer stem cell activity, thereby accelerating the development and progression of colon cancer (Figure 8).